We can’t show the full text here under this license.
Neutrophil traps linked to blood clots in COVID-19
Updated
Abstract
Elevated levels of neutrophil-derived substances in sera were associated with a higher risk of thrombotic events in patients with COVID-19.
- Patients hospitalized with COVID-19 who developed thrombosis exhibited higher levels of neutrophil extracellular traps (NETs).
- Cell-free DNA, myeloperoxidase-DNA complexes, and citrullinated histone H3 remnants were found in patients with thrombosis.
- The presence of neutrophil-derived S100A8/A9 (calprotectin) was also linked to an increased risk of thrombotic events.
- These findings suggest a potential role of hyperactive neutrophils and NET release in COVID-19-associated thrombosis.
- Prophylactic anticoagulation did not eliminate the risk of thrombotic events in these patients.
Simplified